Pembro + Chemo in Metastatic NSCLC - Key Summary of a Practice-Changing Trial Keynote-189

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Pembro + Chemo in Metastatic NSCLC - Key Summary of a Practice-Changing Trial Keynote-189

By Beacon Medical Interchange FEATURING Jack West

244 views

November 2, 2018

Dr. Jack West reviews the trial design, efficacy endpoints, and toxicity results of the KEYNOTE-189 ...
read more ↘ trial of pembrolizumab or placebo added to cisplatin or carboplatin with pemetrexed chemo in advanced non-squamous NSCLC with any PD-L1 expression.
↖ read less

0 Comments